Camilla graduated from the Ji Lin University (China) in 2003 with a B.E. in Bio-pharmaceutical Engineering.  In 2007, she received her Master degree in Medical Biotechnology studies from Flinders University of South Australia. In 2009 she received an ANU PhD scholarship and began her PhD study at The John Curtin School of Medical Research, Australian National University. Her work was to evaluate the adjuvant activity of interferon epsilon (IFN-ε) and Toll-like receptor 9 (TLR9) to enhance HIV-specific mucosal Immunity. After completed her PhD, Cami joined the Professor John Upham’s laboratory at the Lung and Allergy Research Centre, investigating how human rhinoviruses affect innate immune response specifically in plasmacytoid dendritic cells (pDC) regulated, RV-stimulated type I interferon (IFN-I) response in human. She has also been involving in IVC research project, using influenza vaccination to understand and improve anti-viral immunity in Chronic Obstructive Pulmonary Disease (COPD). Her current project (AVIDA) is to investigate anti-viral immune dysfunction in severe asthma varies across inflammatory phenotypes.